BioLASCO Taiwan Co., Ltd. (TPEX:6662)
Taiwan · Delayed Price · Currency is TWD 28.50
-0.20 (-0.70%)
Sep 15, 2026, 12:16 PM CST
BioLASCO Taiwan Market Cap
BioLASCO Taiwan has a market cap or net worth of 729.94 million as of September 15, 2026. Its market cap has decreased by -15.93% in one year.
Market Cap
729.94M
Enterprise Value
675.68M
Revenue
258.04M
Ranking
n/a
PE Ratio
17.92
Stock Price
28.50
ChartMarket Cap Chart
Since January 4, 2018, BioLASCO Taiwan's market cap has decreased from 1.58B to 729.94M, a decrease of -53.83%. That is a compound annual growth rate of -8.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 729.94M | -8.06% |
| Dec 31, 2025 | 793.97M | -6.34% |
| Dec 31, 2024 | 847.76M | -0.30% |
| Dec 29, 2023 | 850.32M | 11.22% |
| Dec 30, 2022 | 764.52M | -1.97% |
| Dec 30, 2021 | 779.89M | -13.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TCI GENE | 947.21M |
| GeneReach Biotechnology | 926.79M |
| NatureWise Biotech & Medicals | 867.37M |
| Meribank Biotech | 834.03M |
| Neith | 793.51M |
| Lukas Biomedical | 766.30M |
| MegaPro Biomedical | 711.93M |
| Taiwan Advance Bio-Pharmaceutical | 644.40M |